Different Effects Of Simvastatin On Migration Of Rat Smooth Muscle Progenitor Cells And Endothelial Progenitor Cells

P. Zhang,L. Huang,Y. X. Liu,X. Y. Zhu,X. M. Han

DOI: https://doi.org/10.3969/j.issn.1007-9688.2010.06.019

IF: 1.9

2010-01-01

Cardiology

Abstract:Objectives To investigate different influences of simvastatin on migration of rat smooth muscle progenitor cells(SPC) and endothelial progenitor cells(EPC),and identification of compounds that differentially inhibit SPC and EPC migration for substantial clinical usefulness.Methods Total mononuclear cells(MNCs) were isolated from marrow of rats by Ficoll density gradient centrifugation,and then the cells were plated on fibronectin-coated culture dishes.SPC outgrew from the culture of MNC in SPC medium(the presence of platelet-derived growth factor-BB and basic fibroblast growth factor),whereas EPC was obtained in EPC medium(the presence of vascular endothelial growth factor).SPC was identified as adherent cells positive for α-smooth muscle actin by indirect immunofluorescent staining.EPC was characterized as adherent cells double positive for DiLDL-uptake and lectin binding by direct fluorescent staining.After 8 days cultured,SPC and EPC were treated with simvastatin(0.01-10 μmol/L) and then continued to be cultured for another 24 h.The migration of SPC and EPC were assayed with modified Boyden chamber assay.Results Simvastatin potently inhibited SPC migration.At concentration as low as 0.01 μmol/L,simvastatin significantly reduced SPC migration compared with control group(0.01 μmol/L simvastatin group versus control group: 39±3 vs.44±3,n=5,P0.05).Being contary to SPC,incubation with simvastatin dose dependently increased EPC migration,at a maximum dose of 1.0 μmol/L(1.0 μmol/L simvastatin group versus control group:37±5 vs.6±3,n=5,P0.01).Conclusions Simvastatin of equal dosage displays a differential effect on migration of SPC or EPC,inhibiting SPC migration but promoting EPC migration.